Cambridge Investment Research Advisors’s MABVAX THERAPEUTICS HLDGS INC MBVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-582,855
Closed -$29K 2453
2019
Q2
$29K Buy
+582,855
New +$29K ﹤0.01% 2172
2018
Q3
Sell
-1,030,310
Closed -$876K 2352
2018
Q2
$876K Buy
1,030,310
+49,967
+5% +$42.5K 0.01% 1054
2018
Q1
$1.48M Sell
980,343
-39,225
-4% -$59.2K 0.02% 742
2017
Q4
$2.14M Buy
1,019,568
+187,834
+23% +$394K 0.03% 564
2017
Q3
$1.62M Buy
+831,734
New +$1.62M 0.02% 608